2026-08-25 - LD The Hague - Genevant Sciences et al. v. Moderna - UPC_CFI_192/2025

Aktenzeichen:
UPC_CFI_192/2025
Datum:
Spruchkörper:
Court of First Instance - The Hague (NL) Local Division
Art:
Order
Parteien:
Genevant Sciences GmbH, Arbutus Biopharma Corporation v. Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc., Moderna, Inc.

Kernaussage: The Hague Local Division allowed the consensual withdrawal of an infringement action and the associated counterclaim for revocation under R.

2026-08-25 - LD The Hague - Genevant Sciences et al. v. Moderna - UPC_CFI_192/2025
🏛️Court of First Instance - The Hague (NL) Local Division• Order
📅2026-08-25
🔢UPC_CFI_192/2025
Parteien & Vertreter
Kläger / Berufungsführer
Genevant Sciences GmbH
Arbutus Biopharma Corporation
Eveline LOTS
Hendrik LAMBERS
Koen BIJVANK
Lilia BOUZORAA
Mark VAN GARDINGEN
Beklagter / Berufungsbeklagter
Moderna, Inc.
Kilian SEIDEL
⚖️Infringement Action
🌐English

routine
The Hague Local Division allowed the consensual withdrawal of an infringement action and the associated counterclaim for revocation under R. 265.1 RoP after the parties settled, holding the application admissible because no final decision had yet issued, and declared both proceedings closed with no need for a cost decision. It refused both requests for reimbursement of court fees. Applying R. 370.9(e) RoP and the Court of Appeal's interpretation of the transitional law, it held that the amended fee rules govern a request filed in 2026, and that under those rules reimbursement is available only before the closure of the written procedure. Because the case had already entered the interim phase, no reimbursement was due.

Entscheidung teilen

Weitere Navigation
Entscheidungen
Rechtstexte
Analysen

Zu Sammlung hinzufügen

0 Einträge hinzufügen zu:

Anmeldung

Registrieren